This titrate-up and taper-down controversy stems from concerns regarding the potential for hyperglycemia upon initiation of total parenteral nutrition (TPN) and for hypoglycemia upon discontinuation.
Sept. 12, 2003 — Hypermanganesemia related to total parenteral nutrition (TPN) is common and may be problematic in patients awaiting intestinal transplant, according to a presentation at the VIII ...